Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions
Recruiting
N/A
Interventional Study
Malignant Skin Neoplasm
Skin Disorder
Skin Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 10 (estimated)
- Sponsor
- Emory University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or Female
* Candidate with skin lesions
* Signed study-specific informed consent prior to study entry
* ≥ 18 years old
Exclusion Criteria:
* Prior surgery or radiotherapy to the area to be treated
Contacts